You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV Genotype 5

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • San Diego, California
  • +24 more
Jul 14, 2021

Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

Completed
  • Hepatitis C
  • HCV
  • San Antonio, Texas
    Texas Liver Institute
Jan 15, 2021

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

    Recruiting
    • Hepatitis C, Chronic
    • P1101 + Ribavirin
    • Chiayi City, Taiwan
    • +7 more
    Jun 30, 2022

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    Has Results
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021

    Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

    Recruiting
    • Hepatitis C Virus Infection, Response to Therapy of
    • Test and treat plus peer mentors
    • Usual care
    • Birmingham, Alabama
    • +3 more
    Dec 9, 2022

    Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

    Completed
    • Hepatitis C
    • Peginterferon alfa-2a
    • +2 more
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Aug 26, 2021

    Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection
    • (no location specified)
    Jul 14, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus Infection
    • (no location specified)
    Jul 8, 2021

    Peripheral T Cell Lymphoma Trial (CHOP+selinexor+5-Azacitidine, CHOP+duvelisib+5-Azacitidine, CHOP+chidamide+tislelizumab)

    Not yet recruiting
    • Peripheral T Cell Lymphoma
    • (no location specified)
    Dec 29, 2022

    Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

    Terminated
    Has Results
    • Hepatitis C
    • Simeprivir (SMV)
    • +2 more
    • Denver, Colorado
      University of Colorado Denver (Leprino Building)
    Aug 16, 2021

    Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

    Completed
    Has Results
    • Hepatitis C Infection
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
    • Phoenix, Arizona
    • +47 more
    Jun 27, 2022

    Angelman Syndrome Trial (60 mg QD Alogabat, 40 mg QD Alogabat, 7 mg QD Alogabat)

    Not yet recruiting
    • Angelman Syndrome
    • 60 mg QD Alogabat
    • +4 more
    • (no location specified)
    Feb 1, 2023

    Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • ABT-450/r/ABT-267, ABT-333
    • Ribavirin (RBV)
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

    Completed
    • Chronic Hepatitis C Virus Infection
    • P1101 + Ribavirin
    • PEG-Intron + Ribavirin
    • Beijing, China
    • +38 more
    Jan 14, 2022

    Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021

    Hepatitis C Virus Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021